fig3
![The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer](https://image.oaes.cc/60e6ea84-bfe6-4b91-84bd-08d56529ad08/cdr60120.fig.3.jpg)
Figure 3. Overall and progression-free survival with ICI plus chemotherapy for the first-line treatment of advanced/recurrent EC. ICI: Immune checkpoint inhibitor; EC: endometrial cancer.
Figure 3. Overall and progression-free survival with ICI plus chemotherapy for the first-line treatment of advanced/recurrent EC. ICI: Immune checkpoint inhibitor; EC: endometrial cancer.
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/